Abbott Labs Pays $1.5B to Settle Off-label Promotion of Depakote
May 07, 2012 | Posted By: Hoyer Law Group, PLLC
Company Maintained Specialized Sales Force to Market Drug for Off Label Purposes; Targeted Elderly Dementia Patients in Nursing Homes Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of the prescription drug Depakote for uses […]
Learn More